|
|
US 7,498,329 B2 |
|
| Salt form of dopamine agonist |
| Stuart Peter Green, Sandwich (United Kingdom); Olivier Alain Lazzari, Sandwich (United Kingdom); Duncan Charles Miller, Sandwich (United Kingdom); and Fabrice Henri Salingue, Sandwich (United Kingdom) |
| Assigned to Pfizer Inc., New York, N.Y. (US) |
| Filed on Feb. 06, 2006, as Appl. No. 11/349,324. |
| Claims priority of provisional application 60/654200, filed on Feb. 18, 2005. |
| Claims priority of application No. 0502509.3 (GB), filed on Feb. 07, 2005. |
| Prior Publication US 2006/0183740 A1, Aug. 17, 2006 |
| Int. Cl. A61K 31/5377 (2006.01); C07D 413/04 (2006.01)
|
